Skip to main content
Log in

Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy

  • Case Report
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

A 7-year-old Japanese boy with a 4-month history of systemic juvenile idiopathic arthritis (s-JIA) experienced disease flare with spiking fever, exanthema and arthralgia. He then developed progressive dyspnea due to severe pericarditis, and proinflammatory hypercytokinemia was suspected. Methylprednisolone pulse therapy was ineffective and echocardiography showed massive pericardial effusion had persisted. Alternatively, subsequent intravenous immunoglobulin (IVIG) therapy resulted in dramatic resolution of the pericardial effusion, and his general condition significantly improved within a few days. This case report may lend further support the use of IVIG for selected patients with s-JIA and severe pericarditis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Frosch M, Roth J (2007) New insights in systemic juvenile idiopathic arthritis–from pathophysiology to treatment. Rheumatology (Oxford) 47:121–125

    Article  Google Scholar 

  2. Fujikawa S, Okuni M (1997) Clinical analysis of 570 cases with juvenile rheumatoid arthritis: result of a nationwide retrospective survey in Japan. Acta Paediatr Jpn 39:245–249

    Article  PubMed  CAS  Google Scholar 

  3. Aghighi Y, Attarod L, Javanmard M (2008) Efficacy of methylprednisolone pulse therapy in children with rheumatoid arthritis. Clin Rheumatol 27:1371–1375

    Article  PubMed  Google Scholar 

  4. Zandman-Goddard G, Blank M, Shoenfeld Y (2009) Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside. Lupus 18:884–888

    Article  PubMed  CAS  Google Scholar 

  5. Levy Y, Sherer Y, Ahmed A, Langevitz P, George J, Fabbrizzi F, Terryberry J, Meissner M, Lorber M, Peter JB, Shoenfeld Y (1999) A study of 20 SLE patients with intravenous immunoglobulin–clinical and serological response. Lupus 8:705–712

    Article  PubMed  CAS  Google Scholar 

  6. Meissner M, Shere Y, Levy Y, Chwalinska-Sadowska H, Langevitz P, Shoenfeld Y (2000) Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis. Rheumatol Int 19:199–201

    Article  PubMed  CAS  Google Scholar 

  7. Grenader T, Shavit L (2004) Intravenous immunoglobulin in treatment of cardiac tamponade in a patient with systemic lupus erythematosus. Clin Rheumatol 23:530–532

    Article  PubMed  Google Scholar 

  8. Silverman ED, Cawkwell GD, Lovell DJ, Laxer RM, Lehman TJ, Passo MH, Zemel LS, Giannini EH (1994) Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric rheumatology collaborative study group. J Rheumatol 21:2353–2358

    PubMed  CAS  Google Scholar 

  9. Tanaka H, Tsugawa K, Suzuki K, Oki E, Nonaka K, Kimura S, Ito E (2007) Treatment of difficult cases of systemic-onset juvenile idiopathic arthritis with tacrolimus. Eur J Pediatr 166:1053–1055

    Article  PubMed  CAS  Google Scholar 

  10. Bennett AN, Peterson P, Sangle S, Hangartner R, Abbs IC, Hughes GRV, D’Cruz DP (2004) Adult onset Still’s disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford) 43:795–799

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroshi Tanaka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aizawa-Yashiro, T., Oki, E., Tsuruga, K. et al. Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy. Rheumatol Int 32, 1359–1361 (2012). https://doi.org/10.1007/s00296-010-1413-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1413-6

Keywords

Navigation